Annual report pursuant to Section 13 and 15(d)

Consolidated Financial Statement Detail (Tables)

v2.4.1.9
Consolidated Financial Statement Detail (Tables)
 12 Months Ended
Dec. 31, 2014
Consolidated Financial Statement Detail [Abstract]  
Receivables
Receivables consisted of the following at December 31, 2014 and 2013 (in thousands):

   
December 31,
  
   
2014
    
2013
  
Trade receivables, net
  
$
2,993
    
$
3,731
  
Other receivables
    
316
      
50
  
Total
  
$
3,309
    
$
3,781
  
Property and equipment
Property and equipment consisted of the following at December 31, 2014 and 2013 (in thousands):

   
December 31,
  
   
2014
    
2013
  
Equipment and furniture
  
$
28,638
    
$
28,365
  
Buildings, leasehold and building improvements
    
9,343
      
9,316
  
Construction-in-progress
    
337
      
225
  
Land
    
310
      
310
  
     
38,628
      
38,216
  
Less:  Accumulated depreciation and amortization
    
(33,508
)
    
(31,760
)
Property and equipment, net
  
$
5,120
    
$
6,456
  
Accrued liabilities
Accrued liabilities consisted of the following at December 31, 2014 and 2013 (in thousands):

   
December 31,
  
   
2014
    
2013
  
Incentive compensation
  
$
4,295
    
$
4,386
  
Accrued payroll and other benefits
    
3,061
      
3,009
  
Accrued clinical trial costs
    
1,424
      
878
  
Other
    
1,112
      
1,661
  
Total
  
$
9,892
    
$
9,934